Publication | Open Access

Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non–small cell lung cancer

Improved Progression-free SurvivalMedicineCancer ManagementDiabetesPathologyDiabetic PatientsBronchial NeoplasmMetformin ExposureOncologyRadiation OncologyLung Cancer